Related Experiment Video
Updated: Jul 26, 2025
06:18
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
Published on: August 18, 2023
2.7K
Considerations for Cell and Gene Therapy Programs Entering the Clinical Space.
Geoffrey A Walford1, An Bautmans1, Carol Cannon1
1Merck & Co., Inc., Rahway, New Jersey, USA.
Clinical Pharmacology and Therapeutics
|June 13, 2023
Summary
Cell and gene therapy (CGT) offers novel treatments by modifying nucleic acids or cells. Early engagement with regulatory bodies like the EMA and FDA is crucial for successful clinical development.
Area of Science:
- * Biomedical science, focusing on advanced therapeutic modalities.
Background:
- * Cell and gene therapies (CGT) represent a diverse class of medical products.
- * These innovative treatments utilize genetic material, cellular alterations, or both.
- * CGT holds significant potential across various therapeutic areas for disease prevention and treatment.
Purpose of the Study:
- * To outline the landscape of cell and gene therapy development.
- * To highlight the importance of early regulatory interaction for CGT products.
Main Methods:
- * Review of the characteristics influencing CGT development, including modality, mechanism, and administration route.
- * Emphasis on the collaborative approach encouraged by regulatory agencies.
Main Results:
- * CGT development is influenced by product-specific factors.
- * Regulatory agencies like the EMA and FDA advocate for early sponsor engagement.
Conclusions:
- * Strategic alignment with health authorities is key for navigating CGT clinical development.
- * Understanding product-specific challenges is essential for successful therapeutic application.
Related Concept Videos
00:59Gene Therapy
25.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K
01:28Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
01:29Microorganisms in Medicine and Therapeutics
72
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
72
01:11Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
01:06Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
00:57Embryonic Stem Cells
3.6K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.6K